España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Allogene Therapeutics
ALLO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.27
-0.19
-7.72%
At close: -
$2.31
0.04
1.77%
After Hours: Nov 15, 5:57 PM EDT
Get Report
Comment
Allogene Therapeutics (ALLO) Forecast
News
Earnings
Allogene Therapeutics (ALLO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Allogene Therapeutics (NASDAQ:ALLO) Stock
Allogene Therapeutics Stock (NASDAQ: ALLO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
Piper Sandler Maintains Overweight on Allogen...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Reiterates Buy on Allogen...
Benzinga Newsdesk
Thursday, November 07, 2024
Allogene Therapeutics Q3 2024 GAAP EPS $(0.32...
Benzinga Newsdesk
Allogene Therapeutics Reports Phase 1 TRAVERS...
Benzinga Newsdesk
Tuesday, November 05, 2024
Allogene Therapeutics To Present Phase 1 Data...
Benzinga Newsdesk
Wednesday, October 30, 2024
HC Wainwright & Co. Reiterates Buy on Allogen...
Benzinga Newsdesk
Tuesday, October 29, 2024
Allogene Therapeutics shares are trading high...
Benzinga Newsdesk
Allogene Therapeutics Receives FDA Regenerati...
Benzinga Newsdesk
Thursday, September 26, 2024
Allogene Therapeutics To Present Pre-Clinical...
Benzinga Newsdesk
Thursday, August 15, 2024
HC Wainwright & Co. Reiterates Buy on Allogen...
Benzinga Newsdesk
Friday, August 09, 2024
Citigroup Maintains Buy on Allogene Therapeut...
Benzinga Newsdesk
Truist Securities Reiterates Buy on Allogene ...
Benzinga Newsdesk
Thursday, August 08, 2024
Oppenheimer Assumes Allogene Therapeutics at ...
Benzinga Newsdesk
A Closer Look at 6 Analyst Recommendations For Allogene Therapeutics
Benzinga Insights
Canaccord Genuity Maintains Buy on Allogene T...
Benzinga Newsdesk
Wednesday, August 07, 2024
Allogene Therapeutics Q2 2024 GAAP EPS $(0.35...
Benzinga Newsdesk
Friday, July 19, 2024
Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges
Vandana Singh
Monday, July 01, 2024
Allogene Therapeutics Announces Patient Scree...
Benzinga Newsdesk
Thursday, June 20, 2024
Allogene Therapeutics Initiates Phase 2 Trial...
Benzinga Newsdesk
Friday, May 31, 2024
Analyst Ratings For Allogene Therapeutics
Benzinga Insights
Piper Sandler Initiates Coverage On Allogene ...
Benzinga Newsdesk
Tuesday, May 21, 2024
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Oppenheimer Maintains Outperform on Allogene ...
Benzinga Newsdesk
Thursday, May 16, 2024
HC Wainwright & Co. Maintains Buy on Allogene...
Benzinga Newsdesk
Wednesday, May 15, 2024
Breaking Down Allogene Therapeutics: 5 Analysts Share Their Views
Benzinga Insights
Truist Securities Maintains Buy on Allogene T...
Benzinga Newsdesk
Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Tuesday, May 14, 2024
Allogene Therapeutics Files For Offering Of U...
Benzinga Newsdesk
Stifel Maintains Hold on Allogene Therapeutic...
Benzinga Newsdesk
Monday, May 13, 2024
Allogene Therapeutics Prices 37,931,035 Share...
Benzinga Newsdesk
Allogene Therapeutics shares are trading high...
Benzinga Newsdesk
Allogene Therapeutics Q1 2024 GAAP EPS $(0.38...
Benzinga Newsdesk
Monday, May 06, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, April 26, 2024
Allogene Therapeutics Awarded $15M Grant From...
Benzinga Newsdesk
Thursday, April 18, 2024
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
Johnny Rice
-
Sponsored
Tuesday, March 19, 2024
HC Wainwright & Co. Reiterates Buy on Allogen...
Benzinga Newsdesk
Friday, March 15, 2024
RBC Capital Reiterates Outperform on Allogene...
Benzinga Newsdesk
Thursday, March 14, 2024
Recap: Allogene Therapeutics Q4 Earnings
Benzinga Insights
Allogene Therapeutics Q4 2023 GAAP EPS $(0.51...
Benzinga Newsdesk
Earnings Scheduled For March 14, 2024
Benzinga Insights
Wednesday, March 13, 2024
Allogene Therapeutics Earnings Preview
Benzinga Insights
Tuesday, March 12, 2024
Allogene Therapeutics And Arbor Biotechnologi...
Benzinga Newsdesk
Tuesday, February 27, 2024
JP Morgan Maintains Overweight on Allogene Th...
Benzinga Newsdesk
Friday, February 16, 2024
Allogene Therapeutics To Restate Previously F...
Benzinga Newsdesk
Monday, February 12, 2024
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Friday, January 19, 2024
HC Wainwright & Co. Maintains Buy on Allogene...
Benzinga Newsdesk
Friday, January 05, 2024
Cell Therapy Focused Allogene Therapeutics' Resource Prioritization A Bold Move, Says Analyst
Vandana Singh
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch